AMSTERDAM,Sept. 14,2024-- Saramonic,a leading power in audio technology,released its latest wireless intercom headset system,the WiTalk9 Series,at a product launch event Team Talk,Now WiTalk at IBC 20
AISep 17, 2024Experience Fast and Smart Ice Making for Refreshingly Cool Moments HONG KONG,Sept. 16,2024-- GoveeLife,an innovator in the smart home industry,today announces the launch of its new smart ice maker,the
AISep 17, 2024NANJING,China,Sept. 14,2024-- On September 2,2024,Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets),an innovative dr
Big DataSep 17, 2024BEIJING,Sept. 16,2024--Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM),a healthcare provider specialized in cancer treatment,research,edu
TechSep 17, 2024NANJING,China,Sept. 16,2024-- Vazyme (688105.SH),a leading life science technology company,significantly contributed to groundbreaking research published in Science Magazine through its innovative pro
Big DataSep 17, 2024BANGKOK,Sept. 16,2024--The Halal Science Center,Chulalongkorn University has developed Halal Route,an application that lists restaurants,lodging,mosques,prayer directions,and tourist attractions in Th
ScienceSep 17, 2024GUANGDONG,China,Sept. 16,2024-- Since the Tang Dynasty (618-907),Guangzhou in Guangdong Province has been a prominent port where Sino-foreign trade flourished,attracting numerous foreign merchants who
SoftwareSep 17, 2024HANNOVER,Germany,Sept. 16,2024-- Hesai Technology (Nasdaq: HSAI),the global leader in lidar technology,is launching its powerful new lidar solution OT128 at Europe\'s biggest commercial vehicle trade
AISep 17, 2024CAAS announces the conference call and webcast information for the Annual Meeting of Stockholders to be held on Tuesday,September 24,2024 at 9:00 AM local time,or 9:00 PM EDT on Monday,September 23,20
ScienceSep 17, 2024In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs),ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an ov
BiologySep 17, 2024
Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.
© ArinstarTechnology
Privacy Policy